Table 1.
Examples of application of the WOE approach in HASPOC's decision-making process – considerations for a subchronic inhalation study waiver.
Pesticide | Chemical A | Chemical B | |
---|---|---|---|
WOE considerations | Toxicity Profile | Low acute inhalation toxicity (no pulmonary effects up to limit concentration) | Acute inhalation toxicity studies showed pulmonary lesions |
Physical/chemical properties | Low vapor pressure and Henry's Law constant-not expected to volatilize | Low vapor pressure and Henry's Law constant-not expected to volatilize | |
Use and exposure patterns | Potential for short- and intermediate-term occupational inhalation exposure | Potential for short- and intermediate-term occupational and short-term residential inhalation exposure | |
Margins of Exposure (MOEs) | Inhalation MOEs: 13,000–25,000,000 (> 10X the level of concern [LOC] of 100) using an inhalation point of departure (POD) selected from an oral study | Inhalation MOEs: 130–28,000 (4 scenarios below 10X the LOC) using an inhalation POD selected from an oral study | |
Information from chemical class or structurally-related pesticides | No structurally related pesticides with inhalation information identified | No structurally related pesticides with inhalation information identified | |
Risk assessment implications | An inhalation study is not expected to provide PODs to change the overall risk picture | An inhalation study may provide more sensitive PODs for risk assessment than the oral studies | |
HASPOC Recommendation | Inhalation study can be waived | Inhalation study is needed |